Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yajuan Lv
Observed names:
YAJUAN LV,
YaJuan Lv
Institutions:
Shandong Provincial QianFoShan Hospital,
Shandong First Medical University
Observed institutions:
Shandong University,
Jinan Central Hospital,
Shandong Provincial QianFoShan Hospital,
Shandong First Medical University
ORCID:
0000-0001-8570-5154
Observed ORCID:
0000-0001-8570-5154
OpenAlex ID:
A5080864289
Methotrexate, doxorubicin, and cisplatinum regimen is still the preferred option for osteosarcoma chemotherapy: A meta-analysis and clinical observation
2019
·
Dapeng Yu
, Shuisheng Zhang
, et al.
·
Medicine
·
113
Prognostic value of preoperative neutrophil to lymphocyte ratio is superior to systemic immune inflammation index for survival in patients with Glioblastoma
2019
·
Yajuan Lv
, Shaohua Zhang
, et al.
·
Clinical Neurology and Neurosurgery
·
39
Quality of life in patients with esophageal cancer receiving definitive chemoradiotherapy or esophagectomy
2014
·
YAJUAN LV
, JIANDONG ZHANG
, et al.
·
Molecular and Clinical Oncology
·
25
PDF
Targeted therapy with anlotinib for patient with recurrent glioblastoma: A case report and literature review
2019
·
Yajuan Lv
, Jiandong Zhang
, et al.
·
Medicine
·
23
Association of CHRNA5-A3-B4 Variation with Esophageal Squamous Cell Carcinoma Risk and Smoking Behaviors in a Chinese Population
2013
·
Yang Wang
, Haijian Wu
, et al.
·
PLoS ONE
·
23
PDF
The Association Between the Incidence Risk of Peripheral Neuropathy and PD-1/PD-L1 Inhibitors in the Treatment for Solid Tumor Patients: A Systematic Review and Meta-Analysis
2019
·
Zhihua Si
, Shuisheng Zhang
, et al.
·
Frontiers in Oncology
·
22
PDF
Targeting complement C5a to improve radiotherapy sensitivity in non-small cell lung cancer
2023
·
Meng Yuan
, Chenlin Wang
, et al.
·
Translational Lung Cancer Research
·
21
PDF
A novel inflammation-based prognostic index for patients with esophageal squamous cell carcinoma: Neutrophil lymphocyte ratio/prealbumin ratio
2019
·
Yajuan Lv
, Jiandong Zhang
, et al.
·
Medicine
·
20
Risk associated with central catheters for malignant tumor patients: a systematic review and meta-analysis
2018
·
Yajuan Lv
, Yong Hou
, et al.
·
Oncotarget
·
18
PDF
The Role of Myeloid-Derived Suppressor Cells in the Treatment of Pancreatic Cancer
2022
·
Peng Dong
, Yu Yan
, et al.
·
Technology in Cancer Research & Treatment
·
15
Identification of N6-Methyladenosine-Associated Long Non-coding RNAs for Immunotherapeutic Response and Prognosis in Patients With Pancreatic Cancer
2021
·
Xinshuang Yu
, Peng Dong
, et al.
·
Frontiers in Cell and Developmental Biology
·
14
PDF
Elevated serum granulocyte-macrophage colony-stimulating factor levels during radiotherapy predict favorable outcomes in lung and esophageal cancer
2016
·
Guodong Deng
, Pingping Hu
, et al.
·
Oncotarget
·
12
PDF
Neoadjuvant immunotherapy improves outcomes for resectable gastroesophageal junction cancer: A systematic review and meta‐analysis
2024
·
Danzhu Wu
, Liyuan Yang
, et al.
·
Cancer Medicine
·
11
Effect of intensity modulated radiotherapy on lymphocytes in patients with esophageal squamous cell carcinoma and its clinical significance
2023
·
Xiufang Tian
, Yong Hou
, et al.
·
Frontiers in Oncology
·
9
PDF
Neoadjuvant Immunotherapy Improves Treatment for Early Resectable Non-Small-Cell Lung Cancer: A Systematic Review and Meta-analysis
2022
·
Peng Dong
, Yu Yan
, et al.
·
Journal of Oncology
·
6
PDF
Nonfunctional ectopic adrenocortical carcinoma in the lung: A case report and literature review
2023
·
Limin Nie
, Shuyun Wang
, et al.
·
Frontiers in Oncology
·
5
PDF
Doses of intensity-modulated radiotherapy and its association with cardiac disease in esophageal cancer patients
2021
·
Jiandong Zhang
, Yajuan Lv
, et al.
·
Annals of Translational Medicine
·
5
PDF
Quality of life and efficacy of temozolomide combined with whole-brain radiotherapy in patients with brain metastases from non-small-cell lung cancer
2018
·
Yajuan Lv
, Jiandong Zhang
, et al.
·
Molecular and Clinical Oncology
·
5
PDF
Cost-effectiveness analysis of pembrolizumab versus chemotherapy in advanced non-small cell lung cancer in China based on real-world studies
2025
·
Ning Wan
, Chen Yang
, et al.
·
Journal of Cancer Research and Clinical Oncology
·
3
PDF
Efficacy and safety of neoadjuvant therapy in gastroenteropancreatic neuroendocrine neoplasms: A systematic review and meta-analysis
2024
·
Yu Yan
, Danzhu Wu
, et al.
·
Journal of Cancer Research and Therapeutics
·
3
Odds ratio of programmed cell death-1 or ligand 1 inhibitor-related endocrine dysfunction in patients with lung cancer: A systematic review and meta-analysis
2019
·
Jian Xie
, Zewen Zhang
, et al.
·
Medicine
·
3
Clinical efficacy and safety of immune checkpoint inhibitors plus anlotinib as secondline or subsequent therapy in extensive stage small cell lung cancer: a retrospective study
2024
·
Yanan Wu
, Yan Zhang
, et al.
·
Clinical & Translational Oncology
·
2
The management of patients with esophageal cancer and coronary artery stenosis undergoing radiotherapy or concurrent chemoradiotherapy: a single-center experience.
2016
·
Hui Luo
, Xiaojian Chen
, et al.
·
PubMed
·
1
Development and validation of nomograms integrating electrolyte, nutritional, and inflammatory indicators to predict survival in advanced esophageal cancer undergoing immunotherapy or radioimmunotherapy
2026
·
Shaotong Tang
, Can Feng
, et al.
·
Journal of Thoracic Disease
Comparison of Efficacy, safety, and cost-effectiveness of pembrolizumab versus chemotherapy for patients with advanced non-small cell lung cancer: a real-world study
2024
·
Ning Wan
, Chen Yang
, et al.
·
Research Square
PDF
Show more works
View as search
Works count:
26
Citation count:
398
H-index:
12
I10-index:
13
Year
Topic
Type